Intratumoral and intertumoral heterogeneity drives EGFR treatment considerations.

ABSTRACT:

SUBMITTER: Lu K 

PROVIDER: S-EPMC9186249 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature